MADISON HEIGHTS, MI / ACCESSWIRE / June 9, 2014
/ Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS:
FITX) is excited and pleased to announce the addition of Dr.
Sam Alawieh to our Board of Directors.
Finding his way back home, Windsorite Dr. Sam Alawieh began his
educational journey at the University of Windsor. “Bill and I
have had many conversations of identifying how to not only
contribute back to Windsor & Essex County, but more importantly
identify on a global platform the raw talent that exists right here
in this city” states Dr. Sam Alawieh. Dr. Alawieh has been
instrumental in acquiring and developing local and global talent
for Creative Edge Nutrition Inc.
“We are proud to announce the addition of Dr. Sam Alawieh
to our Board of Directors. Sam is much more than a great
friend, father and who I consider a brother in this great journey
as we implement and execute a shared vision of the building of our
great company and an industry. Sam has been a valued asset to our
company and its shareholders long before his name was ever
mentioned publicly. A controversial speaker at times, the
genius of Dr. Alawieh comes to light in his many areas of
expertise, including but not limited to pharmaceutical compounding,
pharmaceutical cGMP and workflow models, brand creation and
development, business mergers and acquisitions.
In the coming weeks and months shareholders will learn more
about our global footprint and vertical integration for nutrition,
industrial hemp and medical marijuana that we have been developing
and implementing. Sam and our dynamic team on the US and Canadian
sides of the border have been by my side executing our plans
daily,” stated President & CEO Bill Chaaban.
BIO FOR DR. SAM ALAWIEH
At a young age, the intellect and genius of Sam Alawieh became
evident to his mother and siblings. As a single mother
raising five children; Sam like many children in a large family,
had to find things to keep himself busy. At the age of 6, he
began to read the entire set of Encyclopedia Britannica. He
made notes, observations and drawings on the basement wall of their
rented home.
Once old enough, Sam began to work multiple jobs to help earn
money to contribute to the family’s living expenses. Often at
times working two and three jobs while balancing his
academics. Sam’s amazing work ethic inspires our team to
continue to strive for greatness.
With undergraduate studies in Botany, biochemistry and
physics, Sam went on to earn a Doctor of Pharmacology from
Ferris State University. Below is a brief sample of Dr.
Alawieh’s work experience.
Research, Development & Advanced
Practices
Novel Synthesis
Merck & Wayne State University Chemistry
Fellowship
High affinity hydroxypiperidine analogues for the dopamine
transporter: Stereospecific interactions in vitro and in
vivo.
Novel trisubstituted hydroxy piperidine analogs for the
dopamine transporter. Drug and Alcohol Dependence.
Design, synthesis, and activity of novel cis- and
trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted
piperidine as potential ligands for the dopamine
transporter.
Rxtra Inc.
Novel methodologies for the expedition of cloning sativa
indica & hybrid strains.
Novel synthesis of sativa route nutrients through gamma
irradiated water system applications with key formulation
derivatives.
Investigating cycle acceleration through nutrient peptides
of sativa indica & hybrid strains.
Extrapolations of CBD from THC CBD matrix removed from
strain during cultivation process.
Hybrid cloning methodologies to establish exponentiated
spectrum peaks & troughs of CBD, CBN & THC.
Stabilization of strain activity during maturation processes
through sterile carbon filtered environments.
Development
Novel Synthesis of implant vehicle for the subcutaneous
transport of marijuana derivatives, hormones, drug addiction &
alcohol addiction chemicals.
Novel Synthesis & Development of semi-automated
machinery engineered implant vehicle development, Pending Global
Patent.
Novel Synthesis & Development of Rectal delivery systems
for THC, CBD & Matrix systems.
Novel Synthesis of Buccal delivery systems for THC, CBD
& Matrix systems.
Novel engineering of semi-automated sterile units for the
production of marijuana strain growth isolators
Novel engineering of gamma irradiation water systems for the
engineering of marijuana strain growth isolators
Novel engineering of nutrient matrix feeding systems of
marijuana strain growth isolators
Business Development
Compliance Development
Successful facility developments with USP 797, Iso-Class
Certifications 1-5, cGMP pharmaceutical manufacturing, state
licensures for development and dispensing of
pharmaceuticals.
Established medical population base in 42 states &
development compliant workflow systems, I.T. systems, &
development & dispensing of over 3400 formulations customized
to specified disease states.
Systems Development
Custom Portal E-commerce HIPPAA Compliance Medical Record
System development of online, drop-shipping, e-commerce,
patient-pharmacy-physician communication & ordering
capabilities, with API connectivity for but not limited to,
existing software for medical marijuana fulfillment etc.
Multiple Diagnostics Ventures
Algorithm Development & Automation of therapeutic
Cortisol modalities output in response to direct readings of
diagnostic instrumentation of patient salivary hormonal ELISA
plates.
Analytics workflow novel development for the matrix readings
of but not limited to THC, CBD, CBN potency, sterility &
composition over time utilizing USP governance.
Network Development
Establishment of operational workflow & sales force
recruitment for the development of a successful nationwide sales
force group representing multiple niche lines in pharmaceutical and
medical industries in an effort to establish brand recognition and
visibility.
About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned
subsidiary of Creative Edge Nutrition (OTC Pink: FITX) (PINKSHEETS:
FITX) for the sole purpose of supplying the Canadian public with
pharmaceutical-grade medical cannabis under the newly established
Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc.
has submitted a comprehensive application to become a licensed
producer (LP) of dried marihuana for medicinal purposes and has
received a ready-to-build approval from Health Canada.
http://www.cenbiotechinc.com/
About Creative Edge Nutrition, Inc.
Creative Edge Nutrition is a holding company and a Nutritional
Supplement Company focused on developing innovative, high quality
supplements. The company offers a broad spectrum of capsules,
tablets, and powders, as well as science based products in the
principal categories of weight management, nutrition challenges,
energy and fitness. The Company manufactures under strict GMP
guidelines at GMP Certified and/or FDA registered facilities.
http://www.cenergynutrition.com/ and
https://www.facebook.com/CenergyNutrition
Contact:
FOR INVESTOR RELATIONS
William Swalm
(212) 584-4342
Info@cenergynutrition.com
Source: Creative Edge Nutrition, Inc.
Creative Edge Nutrition (CE) (USOTC:FITX)
Historical Stock Chart
From Jan 2025 to Feb 2025
Creative Edge Nutrition (CE) (USOTC:FITX)
Historical Stock Chart
From Feb 2024 to Feb 2025
